CLOV Biopharma - Ownership and Business Overview

Life ScienceCompany

CLOV Biopharma Ownership

Who owns CLOV Biopharma?

CLOV Biopharma is owned by Right Season Investments. It was acquired on February 12, 2020.

Is CLOV Biopharma PE-backed?

Yes. CLOV Biopharma is owned by private equity investor Right Season Investments.

CLOV Biopharma Business Overview

Where is CLOV Biopharma headquartered?

CLOV Biopharma is headquartered in British Columbia.

What sector is CLOV Biopharma in?

CLOV Biopharma is a life science company.

When was CLOV Biopharma founded?

CLOV Biopharma was founded in 2020.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.

CLOV Biopharma

CLOV Biopharma Corp.

British Columbia
Canada,
www.cloverbiopharma.com

CLOV Biopharma (CBP) performs research and development of cedar leaf oil vapor (“CLOV”) for the purposes of preventing the spread of Coronavirus and other similar potentially pathogenic respiratory viruses, for example, influenza and parainfluenza viruses, and respiratory syncytial virus. CBP intends to manufacture or source a diffuser that is functional with cedar oil that may be effective in killing viruses to prevent them from spreading. CBP has an exclusive license for the right to acquire and use cedar leaf oil vapor, including certain know-how, industry knowledge, and experience relating to CLOV for the pharmaceutical, healthcare, and biotechnology industries. CLOV Biopharma was formed in 2020 and is based in British Columbia.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.